Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
Key Metrics
as of Sep 2026
Market Cap 6,235 Cr
P/E 53.10
Div Yield 0.18 %
Book Value βΉ22.80
52w High βΉ119.00
52w Low βΉ33.00
Face Value βΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
570.00
485.00
484.00
412.00
425.00
466.00
453.00
438.00
455.00
423.00
445.00
422.00
401.00
Expenses
488.00
460.00
438.00
381.00
401.00
424.00
417.00
394.00
404.00
375.00
394.00
388.00
375.00
Operating Profit
83.00
24.00
46.00
31.00
24.00
42.00
36.00
44.00
52.00
48.00
51.00
34.00
26.00
OPM %
14.00
5.00
10.00
7.00
6.00
9.00
8.00
10.00
11.00
11.00
11.00
8.00
7.00
Other Income
5.00
8.00
4.00
30.00
4.00
5.00
5.00
5.00
3.00
4.00
4.00
3.00
2.00
Depreciation
8.00
6.00
10.00
11.00
9.00
16.00
5.00
2.00
6.00
10.00
8.00
8.00
8.00
Interest
5.00
4.00
4.00
4.00
4.00
5.00
1.00
1.00
1.00
1.00
2.00
0.00
0.00
Profit before tax
75.00
23.00
35.00
46.00
16.00
26.00
35.00
46.00
48.00
42.00
44.00
29.00
21.00
Tax %
24.00
33.00
22.00
10.00
26.00
21.00
24.00
24.00
25.00
32.00
27.00
26.00
29.00
Net Profit
56.00
16.00
28.00
41.00
11.00
20.00
27.00
35.00
36.00
29.00
32.00
21.00
15.00
EPS in Rs
1.03
0.29
0.50
0.75
0.20
0.37
0.49
0.64
0.71
0.55
0.63
0.42
0.29
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
1,806.00 1,812.00 1,690.00 1,418.00 1,547.00 1,188.00 853.00 769.00 607.00 595.00 485.00 401.00
Expenses
1,680.00 1,638.00 1,532.00 1,338.00 1,410.00 1,070.00 785.00 701.00 542.00 534.00 424.00 352.00
Operating Profit
126.00 174.00 159.00 80.00 137.00 119.00 69.00 68.00 65.00 61.00 62.00 48.00
OPM %
7.00 10.00 9.00 6.00 9.00 10.00 8.00 9.00 11.00 10.00 13.00 12.00
Other Income
47.00 18.00 14.00 6.00 10.00 12.00 9.00 4.00 4.00 4.00 -3.00 1.00
Interest
16.00 8.00 4.00 2.00 -7.00 2.00 2.00 2.00 4.00 8.00 10.00 9.00
Depreciation
36.00 29.00 33.00 28.00 28.00 30.00 37.00 40.00 34.00 34.00 35.00 39.00
Profit before tax
120.00 155.00 135.00 56.00 127.00 99.00 39.00 29.00 30.00 24.00 13.00 2.00
Tax %
20.00 24.00 29.00 31.00 20.00 1.00 14.00 1.00 0.00 0.00 -1.00 6.00
Net Profit
96.00 118.00 97.00 39.00 102.00 97.00 34.00 29.00 30.00 24.00 13.00 2.00
EPS in Rs
1.73 2.15 1.88 0.76 2.13 2.16 0.75 0.64 0.66 0.53 0.28 0.05
Dividend Payout %
12.00 9.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
110.00 110.00 102.00 102.00 96.00 90.00 90.00 90.00 90.00 90.00 90.00 90.00
Reserves
1,137.00 1,047.00 745.00 651.00 483.00 335.00 194.00 163.00 136.00 106.00 91.00 78.00
Borrowings
208.00 105.00 29.00 25.00 19.00 17.00 133.00 132.00 134.00 169.00 187.00 201.00
Other Liabilities
482.00 517.00 417.00 332.00 473.00 416.00 246.00 230.00 226.00 173.00 156.00 121.00
Total Liabilities
1,936.00 1,778.00 1,293.00 1,110.00 1,070.00 858.00 663.00 615.00 586.00 538.00 524.00 489.00
Fixed Assets
513.00 489.00 307.00 267.00 252.00 225.00 216.00 236.00 264.00 272.00 297.00 322.00
CWIP
22.00 28.00 24.00 17.00 14.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments
124.00 85.00 1.00 0.00 0.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00
Other Assets
1,277.00 1,176.00 960.00 827.00 804.00 631.00 446.00 379.00 321.00 266.00 227.00 167.00
Total Assets
1,936.00 1,778.00 1,293.00 1,110.00 1,070.00 858.00 663.00 615.00 586.00 538.00 524.00 489.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
33.00 32.00 73.00 -91.00 -60.00 51.00 11.00 17.00 63.00 41.00 50.00 51.00
Cash from Investing Activity
-123.00 -322.00 -83.00 -47.00 -32.00 -70.00 -12.00 -13.00 -27.00 -14.00 -27.00 -32.00
Cash from Financing Activity
97.00 300.00 5.00 144.00 66.00 47.00 5.00 0.00 -38.00 -24.00 -27.00 -19.00
Net Cash Flow
7.00 10.00 -5.00 6.00 -26.00 28.00 4.00 4.00 -1.00 3.00 -4.00 0.00
Free Cash Flow
-127.00 -182.00 -8.00 -137.00 -127.00 10.00 -6.00 6.00 37.00 31.00 41.00 46.00
CFO/OP %
46.00 40.00 70.00 -94.00 -26.00 44.00 25.00 26.00 98.00 66.00 81.00 105.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
67.00 65.00 70.00 68.00 59.00 56.00 59.00 64.00 73.00 57.00 66.00 51.00
Inventory Days
88.00 94.00 85.00 87.00 96.00 82.00 91.00 69.00 76.00 65.00 51.00 55.00
Days Payable
103.00 114.00 101.00 87.00 90.00 98.00 113.00 124.00 173.00 125.00 140.00 126.00
Cash Conversion Cycle
53.00 45.00 54.00 69.00 65.00 40.00 37.00 9.00 -24.00 -3.00 -23.00 -20.00
Working Capital Days
122.00 107.00 94.00 98.00 55.00 17.00 -8.00 -34.00 -62.00 -86.00 -10.00 -20.00
ROCE %
8.00 15.00 17.00 8.00 23.00 23.00 10.00 8.00 9.00 9.00 8.00 3.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
35.66
35.66
35.66
35.66
35.66
35.66
35.66
35.66
38.22
38.22
38.22
38.22
FIIs
1.46
1.59
1.62
1.62
1.72
1.94
2.22
2.08
1.67
1.85
2.11
1.29
DIIs
1.28
1.25
1.25
1.49
1.50
1.67
1.64
1.69
2.14
2.15
2.21
2.27
Public
61.59
61.50
61.46
61.22
61.09
60.72
60.46
60.57
57.96
57.76
57.46
58.20
No. of Shareholders
434,912
447,286
453,137
461,853
461,180
468,860
448,361
430,929
348,766
336,019
304,289
304,001
Corporate Actions
24 records
Back to all stocks